Home/ROI
Size the prize
The ROI of neuroinclusion, sized on your numbers.
Set your headcount, your expected adoption and whether you operate in the UK, and the calculator models what neuroinclusion is worth to you across attrition, stress and burnout, engagement, and legal risk. Every effect comes from published research, and every source is named.
Research-backed effects halved before use, with a further 15% cross-category deduction
The calculator
Five lenses, from attrition to total ROI.
The tool runs in full below. Your tailored analysis is generated from exactly what you set.
Take it with you
Your analysis, as a document the board can read
The calculator generates a tailored PDF from your own settings, built to be handed onwards: to your CFO, your board, or the colleague who asks "where do these numbers come from?"
- Your headline figure, on a cover you can present
- The cost breakdown behind each category
- The full calculation appendix, line by line
- The methodology and every source, cited
Download the analysis
Generated from your own settings, and unlocked with one short form that sits right beside the download on the Total ROI tab.
Generate yours →The board conversation
How to build a business case for investing in neurodiversity in the workplace
The strongest case is conservative, specific to your organisation, and honest about its method. Three moves get you there.
Size the cost of doing nothing
Use the calculator above to model attrition, absence, engagement and legal exposure on your own headcount. The output is deliberately understated, which is exactly what makes it defensible in the room.
Ground it in your own baseline
A value case lands harder next to a measured starting point. The free assessment shows where your organisation stands today across six areas, so the board sees the gap as well as the prize.
Present the number with its method attached
The analysis PDF carries the full calculation appendix and every source. When the number travels with its workings, the conversation moves from "is this real?" to "when do we start?"
How the model stays honest
Deliberately conservative, openly sourced
A value case is only useful if it survives scrutiny. The tool is built to be doubted and still stand.
The discipline
Halved, then deducted again
Research-backed effects are halved before use, with a further 15% cross-category deduction so overlapping benefits are never counted twice. The pricing anchor matches the model you have already seen: 20% of headcount, all employees supported.
The evidence
Curated primary sources, named in the tool
- Sull et al., MIT Sloan Management Review, 2022 (Culture 500 dataset, 34M employee profiles)
- Accenture 2023 (346 companies)
- Acas / Saundry & Urwin (2021)
- Irwin Mitchell / HM Courts & Tribunals Service, February 2026
- NeuroBridge 2025 Report (n=210, UK)
- Willis Towers Watson, 2026 Global Medical Trends Report (November 2025)
A representative sample. The complete list, with every citation against every effect, sits inside the tool and ships in the analysis PDF appendix.
Start the conversation
You've seen what it's worth. Now talk it through.
Let's talk about how we make it happen for you.